Fisher Biosciences collaborates with Dyomics
Through a collaboration with Dyomics GmbH, an developer and manufacturer of fluorescent dyes and other markers for biomolecular research, Fisher Biosciences is now able to develop and manufacture an expanded range of products for protein and nucleic-acid detection under the Pierce brand.
Dyomics' products are used in a number of scientific-research, drug-discovery and diagnostic applications -- including Western blotting, multiplex detection of proteins and nucleic acids, protein interaction and antibody arrays, quantitative PCR (polymerase chain reaction), and cellular imaging. When used as markers for proteins and other biomolecules such as DNA and RNA, fluorescent dyes help scientists map protein pathways to better understand the underlying mechanisms of disease.
Under the Pierce brand, Fisher Biosciences currently offers protein-research products based primarily on chemiluminescent and colorimetric detection. The collaboration with Dyomics will expand Fisher Biosciences' capabilities to offer state-of-the-art fluorescently labeled reagents.
Fisher Biosciences is a unit of Fisher Scientific International Inc., which recently acquired an equity interest in Dyomics. This transaction strengthens the existing relationship between the two companies, which had previously partnered in the development of Fisher Biosciences' protein-research products.
Other news from the department business & finance
